Showing 1711-1720 of 3315 results for "".
- Adverum Biotechnologies Announces New GMP Gene Therapy Manufacturing Facilityhttps://modernod.com/news/adverum-biotechnologies-announces-new-gmp-gene-therapy-manufacturing-facility/2478734/Adverum Biotechnologies announced plans for a new Good Manufacturing Practices facility in Durham, North Carolina. Adverum will invest over $80 million in the 174,000-square-foot facility, located in Research Triangle Park (RTP). The site will include four 1,000-liter bioreactors, with space for
- Ocuphire Pharma Initiates LYNX-1 Phase 3 Study Investigating Nyxol in Night Vision Disturbanceshttps://modernod.com/news/ocuphire-pharma-initiates-lynx-1-phase-3-study-investigating-nyxol-in-night-vision-disturbances/2478713/Ocuphire Pharma announced the initiation of patient recruitment and screening in late December for its LYNX-1 phase 3 registration study evaluating the safety and efficacy of Nyxol in night vision disturbances (NVD) at multiple sites in the US. NVD, also known as dim light vision disturban
- Nicox Reports on Enrollment Progress in Mont Blanc Phase 3 Clinical Trial in Glaucomahttps://modernod.com/news/nicox-reports-on-enrollment-progress-in-mont-blanc-phase-3-clinical-trial-in-glaucoma/2478024/Nicox SA announced that over 40 sites have been initiated in the first month of the phase 3 Mont Blanc trial, evaluating NCX 470 for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension. NCX 470 is the company’s novel, second-generation nitric oxide (NO)-donating bimato
- Sensible Medical Announces Partnership Aimed at Restoring Confidence for Safe Surgery During COVID-19https://modernod.com/news/sensible-medical-announces-partnership-aimed-at-restoring-confidence-for-safe-surgery-during-covid-19/2478015/Sensible Medical has announced exclusive distribution rights for the United States and Canada of Toul Meditech’s Operio Mobile and SteriStay Clean Air Zone Systems for surgery and special procedures. The ultraclean H14 filtration system creates laminar airflow at the surgical site, protec
- Vertex Aims for “Virtual Clinic Visits” to Keep Ongoing Studies on Track Amid COVID-19 Pandemichttps://modernod.com/news/vertex-aims-for-virtual-clinic-visits-to-keep-ongoing-studies-on-track-amid-covid-19-pandemic/2477483/Vertex Pharmaceuticals said that due to the COVID-19 pandemic, the company is working with clinical trial sites to enable “virtual clinic visits” and home delivery of study drugs to ensure that ongoing trials continue as planned with the correct monitoring and procedures in place. How
- Novartis Asks Workers in Europe, US and Canada to Work From Homehttps://modernod.com/news/novartis-asks-workers-in-europe-us-and-canada-to-work-from-home/2477394/Due to the COVID-19 outbreak, Novartis released a statement requesting that effective today, its associates within the United States, Europe, and Canada to work from home, with the exception of those working in laboratories, manufacturing sites, and in the field. The measure is valid for 3
- Topcon Announces the Release of Harmony Into the EMEA Regionhttps://modernod.com/news/topcon-announces-the-release-of-harmony-into-the-emea-region/2476835/Topcon has announced the release and clearance of the Topcon Harmony, a class II medical diagnostic software, into the EMEA market. Topcon Harmony is a responsive browser-based software application for on-site or cloud-hosted environments that allows practitioners to connect all of their diagnost
- Bausch + Lomb Launches Sightmatters.com to Help People Living With AMDhttps://modernod.com/news/bausch-lomb-launches-sightmatters-com-to-help-people-living-with-amd/2476325/Bausch + Lomb announced the launch of SightMatters.com, a new educational online resource for people living with age-related macular degeneration (AMD). Bausch + Lomb launched the site to coincide with the start of AMD Awareness Month. The new online resource, which was specifically design
- Study: Glaukos iStent inject Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burdenhttps://modernod.com/news/study-glaukos-istent-inject-implantation-with-concomitant-cataract-surgery-provides-sustained-reduction-in-iop-and-medication-burden/2479620/Glaukos announced that a single-site international study of glaucoma subjects recently published in Ophthalmology and Therapy showed that the iStent inject Trabecular Micro-Bypass System, combined with cataract surgery, achieved a 37% reduction in mean IOP to 14.3 mmHg after 3 years of f
- House Subcommittee Urges FTC to Modernize Contact Lens Verification Processhttps://modernod.com/news/house-subcommittee-urges-ftc-to-modernize-contact-lens-verification-process/2476657/The Health Care Alliance for Patient Safety expressed its support of the House Committee on Appropriations for urging the Federal Trade Commission (FTC) to update the process by which contact lens prescriptions are verified, according to a news